Hexachlorobenzene (HCB) is a dioxin-type chemical that acts mainly through the aryl hydrocarbon receptor. Chronic exposure of rats to HCB increases the activity of malic enzyme (ME). In this report, we show that this increase is correlated with an induction of ME messenger RNA (mRNA) levels, with the maximal HCB effect achieved after 9 days of intoxication. This effect is specific for ME, as other liver enzymes, such as glyceraldehyde-3-phosphate dehydrogenase, phosphoenol pyruvate carboxykinase, and mitochondrial ␣-glycerol-3-phosphate dehydrogenase, are not affected by HCB. The induction of ME mRNA levels is accompanied by an increase in ME promoter activity, as demonstrated by transient transfection experiments performed in rat hepatoma H35 cells. In an attempt to identify the cis-regulatory elements responsible for the HCB effect, different promoter deletions and mutations were used. The results obtained localize the responsive region between positions Ϫ315 and Ϫ177. This region does not contain either consensus xenobiotic response or activating protein-1 elements, the two main mediators of dioxin compounds described to date. In contrast, a thyroid hormone response element (TRE) is located between Ϫ281 to Ϫ261. Deletions and mutations of the TRE element do not respond to HCB, demonstrating that this element mediates the response of this dioxin-type compound. As ME gene expression is regulated mainly by thyroid hormones, we next investigated the role of T 3 receptor (T 3 R) in the ME gene transcriptional induction mediated by HCB. Using Scatchard analysis, we show that neither T 3 R binding features for its ligand nor ␣1 or ␤1T 3 R mRNA levels are changed with the toxic. In gel shift assays, however, we observed that protein/DNA complexes formed on TRE from the ME promoter were induced by HCB. Using an oligonucleotide with a mutation that eliminates the TRE function, we demonstrate a loss of the induced protein/DNA complexes. Together, these data suggest that the dioxin-type compound HCB increases ME gene transcription by modulating the levels of still unidentified nuclear proteins that bind to the TRE element of the ME promoter. (Endocrinology 140: [4142][4143][4144][4145][4146][4147][4148][4149][4150][4151] 1999) 
H EXACHLOROBENZENE (HCB) is one of the most widespread environmental pollutants known. It was formerly used as a fungicide, and it is currently released as a product derived from the synthesis of other polyhalogenated compounds (1) . Chronic exposure of laboratory animals to HCB elicits a number of effects, such as triggering porphyria (2, 3) , induction of liver microsomal enzymes (4) , reduced levels of serum T 4 (3, 5) , reproductive dysfunction (6, 7), immunosupression (8) , and liver and thyroid carcinogenesis (9, 10) . HCB can be classified by its mode of action as a dioxin-type chemical (11) . Almost all of the toxic effects of this kind of compounds are due to their interaction with the aryl hydrocarbon receptor (AhR) (12) , which has been described as a ligand-dependent transcription factor that belongs to the basic-helix-loop-helix superfamily of DNAbinding proteins. It has been proposed that these compounds enter into the cell through the plasma membrane and bind the Ah-receptor complex, consisting of heat shock proteins (90, 70, and 50), an Src-protein kinase, and AhR (13, 14) . After binding, the AhR leaves the complex and moves into the nucleus, where it forms a heterodimer with the Ah receptor nuclear translocator protein (15) and modulates the expression of genes that have specific xenobiotic-or dioxin-responsive elements (XRE or DRE) in their promoters (16) . In addition, the protein kinase of the AhR complex can initiate a phosphorylation cascade. In the case of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), phosphorylation of epidermal growth factor receptor, induction of the Ras/mitogen-activating protein kinase pathway, and activation of the activating protein-1 (AP-1) complex has been described. This second pathway does not require any ligand-induced receptor interaction with XRE sequences (17) .
Taking into account that dioxin-type chemicals modify the expression of a number of metabolic genes, it is of interest to investigate the putative interference between the HCB sig-naling pathway and the transcriptional machinery that modulates the expression of those genes. A previous study has demonstrated that HCB increases the activity of some thyroid-responsive lipogenic enzymes in liver, such as cytosolic malic enzyme (ME: EC.1.1.1.40), glucose-6-phosphate dehydrogenase (EC.1.1.1.49) and 6-phosphogluconate dehydrogenase (EC.1.1.1.44), with no change in the activity of the mitochondrial ␣-glycerol-3-phosphate dehydrogenase (␣GPD; EC 1.1.99.5) (18) . These researchers have also shown that the induction of these enzymes was dependent on thyroid hormone (TH) levels.
In this work, we have focused our attention on ME. The results show that ME messenger RNA (mRNA) levels increase 4-fold in the liver of rats intoxicated for 9 days with HCB. The compound seems to induce specifically the expression of the cytosolic ME gene and not other TH-responsive genes, such as cytosolic glyceraldehyde phosphate dehydrogenase (GAPDH; EC 1.2.1.12) (19) , phosphoenol pyruvate carboxykinase (PEPCK; EC 4.1.1.32) (20) , or mitochondrial ␣GPD (21) . The effect takes place at the transcription level, as ME promoter activity increased after its transfection into H35 hepatoma cells treated with HCB. To understand the molecular mechanisms involved in the transcriptional control of the ME gene by HCB, different deletions and mutations of the promoter were used. The results obtained demonstrate that no consensus xenobiotic elements (XRE) (16) are present in the ME promoter and that a construct containing the AP-1 element (22, 23) does not respond to HCB. Interestingly, we demonstrate that the TH response element (TRE) located between Ϫ281 to Ϫ261 (24), is the ciselement responsible for the HCB effect. ME gene expression is regulated mainly by TH (24) acting through the TRE present in the ME promoter (25) . This fact and the above-mentioned observation that HCB induces ME activity only in the presence of TH (18) led us to hypothesize that the TH receptor could be the putative transcription factor directly affected by HCB and responsible for ME mRNA induction. HCB could also affect the receptor binding parameters for its ligand. The results obtained here indicate that HCB does not induce changes either in T 3 receptor (T 3 R) binding characteristics for its ligand or in ␣1 or ␤1 TH mRNA levels. Using the Ϫ281 to Ϫ261 TRE of the ME promoter, however, we found a clear induction of protein/ DNA complexes using liver nuclear extracts from rats treated for 9 days with HCB. Similar results were obtained in H35 cells treated with 50 nm HCB for 48 h. Competition experiments demonstrate that the complexes are specific, and by using a mutated TRE we directly implicate this element in the induction observed. Although the nature of these nuclear proteins remains to be elucidated, our results describe for the first time the induction of ME gene transcription by a dioxin-type chemical, and this effect involves the TRE cis-element of the ME promoter, but not the ␣1 or ␤1 receptor. However, we cannot exclude that other nuclear receptors and/or associated proteins could be induced in response to HCB and will be the final inductors of ME gene transcription.
Materials and Methods Animals
Female Wistar rats (160 -180 g at the start of the experiment) were maintained in environmental conditions consisting of a 12-h light, 12-h dark cycle at 22 C. The NIH Guidelines for Human Care and Use of Laboratory Animals were followed. HCB (1 g/kg BW) was administered daily through a stomach tube. The fungicide (40 mg/ml) was dissolved in water containing Tween-20 (0.5 ml/100 ml). Control animals received equal volumes of the appropriate vehicle (Tween-20). The dose used elicited clear manifestations of hepatic porphyria, as previously reported (18) . Animals were killed by decapitation; the livers were rapidly removed, immediately frozen in dry ice, and stored at Ϫ80 C. HCB for rat treatment was of commercial grade (95% pure) and was a gift from Compañ ía Química S.A. (Buenos Aires, Argentina).
Cell culture
H35 rat hepatoma cells (H4IIE; ATCC CRL 1548, American Type Culture Collection, Manassas, VA) were cultured in DMEM with 5% FCS, 5% newborn calf serum, 100 g/ml streptomycin, 100 IU/ml penicillin, nonessential amino acids, and sodium pyruvate. The HCB used in cell culture was chemical grade (99% pure; Sigma Chemical Co., St. Louis, MO); it was dissolved in ethanol and used at a final concentration of 10 or 50 nm.
Parameters of thyroid function
T 4 and T 3 levels were measured in hepatic tissue by specific, highly sensitive RIA as described by Morreale de Escobar et al. (26) . In brief, methanol was added to the still frozen tissue samples and homogenized, with tracer amounts of [
131 I]T 4 and [ 125 I]T 3 added to each homogenate. This was followed by the addition of chloroform, in a volume double that of methanol, centrifugation, and a further extraction of the pellet with chloroform-methanol (2:1). This extracts more than 90% of the endogenous and added iodothyronines. The iodothyronines are then backextracted into an aqueous phase and purified by passing this phase through a Bio-Rad Laboratories, Inc. AG 1ϫ2 resin columns (Bio-Rad Laboratories, Inc., Richmond, CA). After performing a pH gradient, the iodothyronines are eluted with 70% acetic acid, evaporated to dryness, and dissolved in RIA buffer. Each extract is extensively counted to determine the recovery of the tracer added to each sample in the initial homogenate. The samples are subjected to highly sensitive RIAs for the determination of T 4 and T 3 ; the limits of detection are 2.5 pg for T 4 and 1.5 pg for T 3 /tube. Each sample is processed in triplicate at two or more dilutions.
For Scatchard analysis, liver nuclei were prepared as previously described (27) . The nuclear pellet was resuspended in 5 ml SMT buffer (0.32 m sucrose, 1 mm MgCl 2 , and 20 mm Tris, pH 7.8) containing 2 mm dithiothreitol. The DNA content was determined by the method of Labarca and Paigen (28 Ϫ7 m). All determinations were performed in duplicate. After incubation (135 min, 20 C), the nuclei were cooled to O C and centrifuged. The nuclear pellet was washed twice in SMCT containing 0.5% Triton X-100, and bound radioactivity was determined in a ␥-counter. 
RNA extraction and Northern blot analysis
Livers from control and treated rats were homogenized in guanidinium isothiocyanate, and total RNA was extracted after centrifugation through a cesium chloride cushion (29) . Total RNA from cells was extracted as described previously (30) . Polyadenylated [poly(A) ϩ ] RNA was obtained using the mRNA separator kit (CLONTECH Laboratories, Inc., Palo Alto, CA). Samples of total RNA or poly(A) ϩ were electrophoresed in 1% agarose gels containing 2.2 m formaldehyde (31), blotted on Nytran membranes (Schleicher & Schuell, Inc., Keene, NH) and hybridized using the following rat probes: ME complementary DNA (cDNA) (32) , GAPDH (33) , PEPCK (34), ␣GPD (35), and ␤-actin (36). The ME probe was prepared by digesting the plasmid pMEB, which contains full-length ME cDNA, with BamHI and BglII. The GAPDH insert sub-cloned in pGEM plasmid was obtained by digestion with PstI. PEPCK cDNA subcloned in pPCK10 was obtained after digestion with PstI. The ␣GPD insert subcloned in pBluescript IISK was obtained by digestion with EcoRI. All probes were isolated and labeled by random oligopriming to a specific activity of 1 ϫ 10 9 cpm/DNA. When total RNA was used, the filters were stained with methylene blue to correct for the amount of applied RNA. In the case of poly(A) ϩ , filters were hybridized with the ␤-actin probe. The levels of mRNA were determined by autoradiography and quantitated by densitometric scanning. The results were expressed as an intensity percentage compared with the control expression of each experiment.
Ribonuclease (RNase) protection assay
A 265-bp XbaI/EcoRI restriction fragment of the c-erbA (37) (TR␣1) probe or the 232-bp PstI-BamHI restriction fragment of the rat T 3 receptor ␤ (38) (TR␤1) probe was cloned in the pBS ϩ SK vector as described previously (39) . 32 P-Labeled antisense riboprobes were generated using T7 RNA polymerase, [␣-
32 P]CTP (800 Ci/mmol; Amersham Pharmacia Biotech, Aylesbury, UK) and the Riboprobe Transcription Kit (Promega Corp., Madison, WI) according to the manufacturer's instructions. As an internal control to correct for total RNA loading, an additional 28S ribosomal antisense riboprobe was transcribed from pT7RNA-28S. The mRNA levels were analyzed by RNase protection with the RPA II assay kit (RPA II RNase protection assay kit, Ambion, Inc. Austin, TX), essentially as described by the manufacturer. TR␣1 and TR␤1 (5 ϫ 10 5 cpm) and 5 ϫ 10 4 cpm 28S riboprobes were incubated overnight with 20 g total RNA. After hybridization, samples were digested at 37 C with a RNase mixture (2.5 U/ml RNase A and 50 U/ml T1 RNase) for 30 min for TR␣1 and 2 h for TR␤1 and 28S. The protected fragments were precipitated and electrophoresed on a denaturing 5% acrylamide gel, dried, and visualized by autoradiography. The TR␣1 and TR␤1 mRNA levels and ribosomal 28S RNA were quantified by densitometric gel scanning in an Instantimager (Packard, Meridien, CT), and the relative TR␣1 and TR␤1 mRNA levels were expressed in arbitrary units after correction with 28S ribosomal RNA levels.
Transfection assays
5Ј-Deletions of the rat ME promoter [pME 882-chloramphenicol acetyltransferase (CAT), pME 315-CAT, and pME 177-CAT] (22) and the mutated constructs, pME 882/⌬Cla-CAT and pME 882/m277-CAT (40), were used to study ME promoter activity. Point mutagenesis was generated by Desvergne et al. (40) using the oligonucleotide-directed mutagenesis system (Amersham Pharmacia Biotech) to create ClaI sites at positions Ϫ260 and Ϫ298 of the ME gene. Oligonucleotides encompassing the ME gene sequences from Ϫ240/Ϫ274 and Ϫ285/Ϫ315 with different mutations, extensively described previously (40) , were annealed to M13 gene fragment of pME882-CAT. After the synthesis, the mutated fragment was inserted in the KpnI/PstI site of pUCATSV I (22) generating pME 882/ClaI-CAT. An internal deletion was then obtained by ClaI digestion followed by ligation to generate pME-882/⌬ClaI-CAT. The mutation pME 882/m277-CAT was generated by a point mutation introduced at Ϫ277 (A3 C).
Ten micrograms of each construct were transiently transfected by the calcium phosphate method (41) together with 2 g of a plasmid directing luciferase expression from the cytomegalovirus (CMV) promoter (42) to correct for transfection efficiency. After transfection, half of the plates were treated with 50 nm HCB for 48 h, cell extracts were prepared, and CAT as well as luciferase activities were assayed as previously described (43, 44) .
Preparation of nuclear extracts and gel shift assay
Nuclear extracts were prepared following the method of Gorski et al. (45) for liver and the method of Andrew and Faller (46) for cells. Proteins were determined by the Bradford method (47) using the Bio-Rad kit (Bio-Rad Laboratories, Inc.) with a BSA standard. Gel shift assays were performed with oligonucleotides labeled with T 4 polynucleotide kinase and [␥- 32 P]ATP and annealed as previously described (48) . For binding reactions, 5 or 10 g nuclear protein from cells or rat liver, respectively, were preincubated in a binding reaction mixture containing 40 mm HEPES (pH 7.9), 200 mm KCl, 0.5 mm dithiothreitol, 0.2 mm EDTA, 5% Ficoll, and 3 g poly(dI-dC) for 15 min on ice. In competition experiments, the unlabeled competitor oligonucleotide was added in excess (100-fold). Then, 50 pg labeled oligonucleotide were added to the mixture and incubated for 30 min at room temperature. The resulting DNAprotein complexes were separated from free DNA on a 5% polyacrylamide gel (29:1, acrylamide-bisacrylamide). Gels were resolved at 20 mA in a cold room in 0.5 ϫ TBE (1 ϫ TBE is 90 mm Tris, 90 mm boric acid, and 1 mm EDTA, pH 8) before being vacuum dried and exposed to x-ray film at Ϫ70 C.
Statistical analysis
The mRNA levels and the promoter activity results were expressed as an intensity percentage compared with the control expression of each experiment. Each value represents the mean Ϯ sd of three different experiments. The values from RIA T 3 and T 4 as well as from the Scatchard analysis are the mean Ϯ sd. Statistical significance between the control and the different treatments was determined by Student's t test. Differences are considered significant at P Ͻ 0.05.
Results

Hexachlorobenzene is a potent inductor of ME gene expression in liver and does not affect other TH-responsive genes
We first studied whether the reported increase in ME activity due to HCB (18) correlates with an increase in ME mRNA levels. Rats were intoxicated daily by gastric intubation with HCB for 9 or 15 days. These intoxication periods were chosen because ME activity reached 75% of its maximum value after 9 days of treatment with HCB (18) and were extended to 15 days when other manifestations of hepatic intoxication become evident (49) . The percentage of ME activity is referred to as a maximum determined after 4 weeks of treatment in previous studies (18) . After death, livers were excised, and total RNA was extracted and analyzed by Northern blot. Treatment with HCB for 9 days strongly increased ME mRNA levels (4-fold over control values; Fig. 1 ). After 15 days of treatment, a 2-fold increase in ME mRNA compared with the control value was observed. As ME is a cytosolic lipogenic enzyme mainly regulated by TH (24), we next investigated whether HCB affected the expression of other cytosolic thyroid-responsive enzymes involved in different metabolic pathways. We analyzed the HCB effect on GAPDH, a glucolytic enzyme, and on PEPCK, a key gluconeogenetic enzyme. We performed Northern blot analysis using total RNA from liver of control and intoxicated rats. HCB did not alter either GAPDH or PEPCK mRNA levels (Fig. 1) .
We also studied the effect of HCB on the mRNA levels of a mitochondrial TH-responsive enzyme, ␣GPD. As mRNA levels of liver ␣GPD are low, we used poly(A) ϩ mRNA instead of total RNA to perform Northern blot analysis. No changes in ␣GPD mRNA levels were observed after treatment with HCB ( Fig. 1) , confirming a previous report that showed no effect of HCB on ␣GPD activity (18) . Our results demonstrate that the HCB effect is specific for the ME gene and that the toxic does not have a generalized action on the expression of other cytosolic or mitochondrial TH-dependent enzymes.
HCB stimulates ME promoter activity through the TRE element
To determine whether the HCB-induced increase in ME mRNA levels was due to an increase in ME gene transcription, we followed a transfection experimental approach using H35 hepatoma cells. As in rat liver, these cells respond to HCB by increasing the ME mRNA levels after 48 h of treatment in a dose-dependent manner (Fig. 2) . The construct pME 882-CAT (23, 40) , which contains the full-length ME promoter (Fig. 3A) , was transiently transfected into H35 cells. Half of the cell plates were then treated for 48 h with 50 nm HCB, a concentration that showed maximal ME mRNA induction in Northern blot experiments (Fig. 2, line 3) . ME promoter activity was determined by assaying crude cell extracts for CAT activity, whereas luciferase activity derived from the cotransfected CMV-Luc was used to correct for variability in transfection efficiency. The results obtained demonstrate that HCB increases ME promoter activity 3-to 4-fold (Fig. 3B) , indicating that its effect on ME gene expression takes place at the transcriptional level. To define the region within the promoter responsible for the HCB response, several 5Ј-deletions (23, 40) of the ME promoter (Fig.  3A) were transfected as described above. As shown in Fig. 3B , the deletion pME-315 responds to HCB as the full promoter does, whereas no response was found with the deletion pME-177. This data suggest that cis-acting elements that respond FIG. 1. Effect of HCB on TH-responsive liver enzyme gene expression. mRNA levels of cytosolic ME, GAPDH, and PEPCK and mitochondrial ␣GPD were measured in rat liver after HCB treatment (1 g/kg BW). The pesticide was administered to rats for 9 or 15 days. Total RNA (30 g) was used to determine ME, GAPDH, and PEPCK transcripts, whereas 5 g poly(A) ϩ were used for ␣GPD mRNA levels. A, Upper panel, A representative Northern blot of each experimental group. The sizes of the mRNAs are indicated. A, Lower panel, The methylene blue staining of membranes with total RNA in which the positions of ribosomal RNAs are indicated. Membranes with poly(A) ϩ were hybridized with ␤-actin. B, Quantification of mRNAs, after correction with 28S or ␤-actin mRNA, by densitometer scanning of autoradiograms from three independent experiments. The data are the mean Ϯ SD of three independent experiments. In the case of ME, control levels can be detected and measured after longer exposures.
to HCB should be located in a region between Ϫ177 to Ϫ315 of the ME promoter. To identify this cis-regulatory element, we first analyzed by computer whether any of the previously described response elements for dioxin-type compounds (DRE/XRE) were present between Ϫ177 to Ϫ315. No consensus DRE or XRE were found in this region. However, a previously described functional TRE is located within this region (from Ϫ261 to Ϫ281) (25) . To assess whether the TRE element is involved in the HCB response, two constructs containing, respectively, a deletion of the entire TRE (pME882/⌬ClaI) or a punctual mutation on nucleotide 277 (pME-882/m277) together with the full promoter with an additional ClaI site (Fig. 3C) were transfected into H35 cells treated or not with 50 nm HCB. Again, the full promoter with the ClaI site responds 3-to 4-fold to HCB, as the ClaI mutation does not modify the activity of the promoter (40) . The response was totally lost when the TRE element was either deleted or mutated (Fig. 3D) . These data strongly suggest that the TRE of the ME promoter is involved in the HCB response.
Moreover, this transfection analysis also demonstrates that the AP-1 element of the ME promoter (22, 23) located at Ϫ132 bp (Fig. 3A) , which has been described to mediate the dioxin-response in other genes (17) , is not involved in the HCB regulation of ME gene promoter, as the construct pME-177 that contains this element does not respond to HCB. In addition, no changes were observed with the toxic in either the AP-1/DNA complex or the levels of c-Fos and c-Jun proteins (data not shown).
Parameters of thyroid function in HCB-intoxicated rats
As ME gene transcription is directly controlled by TH (24) and the levels of serum TH have been described to be altered in the plasma of HCB-treated rats (18), our next aim was to determine whether HCB induces ME gene transcription through the TRE present in the ME promoter. We first analyzed the thyroid status of the intoxicated animals. Previous data have shown that serum T 4 levels are reduced after 9 and 15 days of HCB intoxication, whereas T 3 levels are not significantly altered (50, 51) . Using sensitive RIA assays, we measured hepatic T 4 and T 3 levels after HCB treatment. In contrast with the data on serum TH levels, we found that hepatic tissue levels of T 4 are not affected by the pesticide, whereas T 3 levels are slightly reduced at both times of treatment (Table 1) . We next examined whether HCB affects T 3 binding affinity for its receptor or induces changes in the number of sites. Nuclei from control and intoxicated rats were isolated, and Scatchard plot analysis was performed. Table 2 shows that neither 9 nor 15 days of HCB treatment affected the kinetic parameters of T 3 R.
TR (␣1 and ␤1) mRNA levels are unaltered by HCB treatment
Most parameters of thyroid status studied to date were unaltered or showed only very small changes to explain the increase found in ME gene expression after HCB treatment. TR is the primary transcription factor that mediates the action of TH. There are various isoforms of TRs produced from two different genes, ␣ and ␤ (52). TR␣1 and TR␤1 are able to bind to ME TRE (25) . Therefore, another parameter potentially responsible for the increase in ME gene expression is a change in the expression levels of TRs. We studied the mRNA levels of TR␣1 and TR␤1 after HCB treatment. Total RNA from the livers of each experimental group was isolated, and TR␣1 and ␤1 mRNA levels were determined by RNase protection assay. The TR␣1 probe is 328 nucleotides (nt) long and contains, in addition to 63 nt of vector sequences, 265 nt complementary to TR␣1 mRNA (39) . The TR␤1 probe is 263 nt long and contains, in addition to 31 nt of vector sequence, 232 nt complementary to TR␤1 (39) . A major 265-or 232-nt-long protected RNA fragment was detected, respectively, for TR␣1 or TR␤1 in livers of control rats and in 9-and 15-day HCB-treated rats (Fig. 4, A and B) . Other fragments of smaller size were also detected, presumably originating from spurious cleavage by RNase. The most abundant 265-and 232-nt fragments were used in densitometric analysis, as we observed that all fragments are identically regulated. Scanning densitometry of three separate experiments showed the same levels of TR␣1 and TR␤1 mRNA in all groups (Fig. 4C) , corroborating the lack of HCB effect observed on T 3 R concentration by Scatchard analysis (number of sites; Table 2 ).
HCB increases protein/DNA complexes formed on TRE from the ME promoter
As TR (␣1 and ␤1) mRNA levels do not change after HCB treatment, we determined whether the toxic affects the binding of other nuclear proteins to the TRE from the ME promoter. We carried out gel shift assays with nuclear extracts from livers of control and 9-and 15-day HCB-treated rats and the oligonucleotide (5Ј-GTTGGGGTTAGGGGAGGACAG-3), corresponding to the TRE element from the ME gene promoter (Ϫ281 to Ϫ261; Fig. 5A ). Three protein/DNA complexes were found in nuclear extracts of control rat livers (lane 2), although the two top complexes (1 and 2) were almost undetectable. Interestingly HCB treatment for 9 days induced the binding capacity of the three complexes, but this induction was much more pronounced in the top complexes 1 and 2 (lane 3). Treatment with HCB for 15 days did not modify the intensity of the complexes compared with that in control rats. These three complexes are specific, as they are displaced by a 100-fold excess of unlabeled TRE (lane 5), but not by an unrelated oligonucleotide (lane 6). Similar results were obtained when nuclear extracts from control or 50 nm HCB-treated H35 cells were used (Fig. 5B) . To have a more direct demonstration of the TRE implication, we performed gel shift assays with a mutated TRE (5Ј-GTTGGGGTTAGGGGAGtAaAGЈ-3). This mutated TRE, in which the Ϫ264 G has been replaced by a T and the Ϫ262 C has been replaced by an A, virtually eliminates the TRE function, as demonstrated in transfection experiments by Desvergne et al. (40) . The results obtained using nuclear extracts from livers of 9-day treated rats (Fig. 5A, lane 7) or from 50 nm HCBtreated cells (Fig. 5B, lane 4) indicate a loss of binding of all of the induced hepatic DNA-binding activities. These data strongly suggest that still unidentified nuclear proteins that bind to the TRE element of the ME are involved in the HCB-mediated regulation of this gene.
Discussion
In this paper, we have demonstrated for the first time that HCB, a dioxin-type chemical, is a potent inductor of ME gene transcription. These data are in agreement with previous   FIG. 3 . HCB effect on ME promoter activity and identification of the HCB responsive region. A and C, Schematic diagram of the full ME promoter (pME-882), the different deletions (pME-315 and pME-177), and the deleted (pME-882/⌬ClaI) or mutated (pME-882/m277) promoters generated over the pME-882ClaI construct linked to the CAT reporter gene. Binding sites detected previously are indicated with the corresponding names of the elements. B and D, ME promoter activity derived from 10 g of each construct transiently transfected into H35 cells. After transfection, half of the plates received 50 nM HCB. Forty-eight hours later, the cells were harvested, and CAT and luciferase activities were determined. The ME promoter activity (CAT/luciferase) is expressed as the fold induction over the control levels (ϭ1) of untreated cells. The results are the mean Ϯ SD of four independent experiments. work showing that HCB increases the activity of various TH-responsive lipogenic enzymes in liver (18) and with other reports that showed the same effect on ME activity for TCDD (53) (54) (55) . It has also been shown that HCB, TCDD, and other related dioxin-type compounds decrease plasma T 4 levels with no change in T 3 levels (49, (53) (54) (55) . However, in the present study we demonstrate that HCB does not alter T 4 levels and only slightly decreases T 3 levels when TH are measured directly in the liver. These differential effects of HCB on TH could be due to the production of some HCB metabolites. In this regard, pentachlorophenol, the main HCB metabolite, competes strongly with T 4 for serum carrier proteins (56) . This competition could result in an increase in free T 4 entering the liver. However, preliminary results from our laboratory indicate that HCB decreases 5-deiodinase activity in liver; consequently, less T 4 is converted to rT 3 . In addition, we observed a decrease in 5Ј-deiodinase, resulting in less T 4 /T 3 conversion. Whether the effect of HCB on deiodinase activity is a direct effect of HCB or is mediated by its metabolite pentachlorophenol remains to be elucidated. Based on the above explanation it is unlikely that HCB induces a transient hyperthyroidism in liver. Moreover, the discrepant response of hepatic mitochondrial and cytosolic enzymes mRNA levels does not support the hypothesis that HCB-treated rats are hyperthyroid.
In addition, the results obtained suggest that TH availability for TH nuclear receptors is not basically affected by the pesticide. These results are compatible with those reported previously, showing that HCB did not change hepatic tissue thyroid status (18) . We have further shown that HCB does not modify the number of T 3 R sites or its ligand binding affinity, nor are TR␣1 or TR␤1 mRNA levels affected. The fact that this compound induces not only ME activity, but also that of other enzymes of the lipogenic pathway, such as glucose-6-phosphate dehydrogenase and 6-phosphate dehydrogenase (18) , suggests that NADPH-generating enzymes could be specifically affected by HCB. Taking into account that generation of NADPH enzymes could be involved in detoxification metabolism, their induction by HCB could be viewed as a defensive strategy of animals to the aggression of xenobiotic agents. This is reinforced by the fact that dioxins and other lipophilic xenobiotics produce a rise in other liver detoxification enzymes, such as the cytochrome P450 system (CYP), as well as glucuronyl transferases (57, 58) . With respect to the HCB doses used, it is of interest to mention that the dose assayed elicits in rats a specific effect on the ME gene, as the toxic does not affect the expression of other hepatic enzymes, such as the cytosolics GAPDH and PEPCK or the mitochondrial ␣GPD. Furthermore, the dose of 50 nm used in H35 cells is on the order of magnitude of the doses used in most of the studies with compounds whose action is mediated by the AhR (59, 60) .
The data reported in the present work showing that HCB increases ME promoter activity led us to identify the cis-and trans-regulatory elements involved in the HCB induction of ME gene transcription. The study of the mechanism of action of dioxin-type compounds is becoming increasingly relevant (12, 13) . After its interaction with HCB, AhR trans-locates to the nucleus, where the AhR-Ah receptor nuclear translocator heterodimers bind to cis-elements called XRE (16) . By computer analyses, no consensus XRE was found in the 882-bp fragment of the ME promoter studied. As the other mechanism of action for dioxin-type compounds is the phosphorylation cascade involving the AP-1 element and c-Fos/c-Jun proteins (17), we investigated the possible involvement of this element in the ME regulation mediated by HCB. The fact that a ME promoter deletion containing the AP-1-binding site does not respond to HCB suggests that this element is not the mediator of the induction found. This result together with the finding of no changes in the levels of AP-1 complexes or in the c-Fos/c-Jun proteins (not shown) are different from those reported by Ashida and Matsumura (61) , which showed an increase in the AP-1 complex in response to TCDD as well as an increase in c-Fos and a decrease in c-Jun levels. These differences could be due to the fact that these researchers studied the effect of a different compound (TCDD) in the liver of another species, the guinea pig. The length and mode of intoxication are also totally different in the two experimental situations.
Interestingly, the cis-element involved in the HCB regulation of ME promoter is the TRE, as we have extensively demonstrated in the transfection experiments reported in the present work. The dioxin-type chemicals increase malic enzyme activity only in the presence of TH (18, (53) (54) (55) , suggesting that this hormone is a permissive factor for the action of these chemical compounds. ME expression is regulated by nuclear T 3 receptor, and although T 3 R (␣1 and ␤1) does not seem to be directly responsible, other transcription factors interacting with the TRE of ME or with the T 3 R could be involved in the mechanism of action of HCB. In this respect, we found an increase in the protein/TRE-ME complexes when nuclear extracts were used from rat liver treated for 9 days with HCB. At this time of intoxication, there is an increase in all of the complexes (1, 2, and 3), although the major increase was observed in complexes 1 and 2. Similar results were obtained in H35 cells. The induction observed in the bottom complex (complex 3) is not constant, suggesting that the main protein/TRE-ME complexes induced in response to HCB are the top complexes 1 and 2. The nature of the protein(s) that forms part of these complexes remain to be elucidated, although they should be related to the TR, because in a gel shift experiment with a mutated TRE that does not respond to TH (40) , the binding activity of the three complexes is loss. In addition, preliminary competition experiments using different consensus TREs as competitors suggest that the proteins induced could be members of the nuclear hormone receptor superfamily. However, more experiments are required to definitively establish the identity of such proteins. T 3 R, along with receptors for retinoic acid, 9-cis-retinoic acid (RXRs), vitamin D, steroid hormone and peroxisome proliferator activated-receptor (PPAR), belongs to this superfamily of transcription factors (52) . T 3 R binds to TRE as homodimer or heterodimer with RXR. It has been demonstrated that the interaction of RXR-T 3 R with TRE activates transcription. Taking into account that RXR also forms heterodimers with retinoic acid receptor, vitamin D receptor, PPAR, and orphan receptors, the response of a cell to the TH depends not only on the levels of TH and T 3 R, but also on the relative RXR and other nuclear receptor levels that compete with T 3 R to bind with RXR. In future studies, it would be interesting to measure the levels of RXR and other nuclear receptors after HCB treatment. Another possibility that could be considered in future studies is whether coactivators or corepressors of the TRAC family (T 3 receptor-associating cofactors) (52) are affected by HCB. Finally, the HCB-mediated induction of ME promoter activity could also be explained by the fact that this gene is controlled by the peroxisome proliferator-activated receptor that binds to an element (PPRE) located at 338 bp (62) . Both AhR and PPAR mediate the induction of different hepatic CYP isoenzymes by their ligands (63) . The induction of ME by both receptor-ligand systems provides the NADPH required for the subsequent induction of the CYP activity. However, the fact that the promoter deletion Ϫ315 that does not contain the ME-PPRE element still responds to HCB suggests that this element does not mediate the induction observed.
In summary, these data confirm that we have identified the cis-regulatory element that mediates ME gene transcription in response to HCB. In addition, we found that nuclear proteins bound to this element are induced in response to this compound. However, the nature of this trans-acting element still remains to be identified. Future experiments will elucidate the participation of other nuclear receptor or associated proteins in the HCB regulation of ME gene expression.
